Summary Receiver Operator Characteristic (SROC) curves were estimated using the Moses-Shapiro-Littenberg model weighted by sample size. Results were compared to the hierarchical SROC model. Summary diagnostic odds ratios, with 95% CIs, were calculated for the odds of having unresectable disease given a positive laparoscopy compared to a negative laparoscopy.
To assess the effect of preoperative staging using staging laparoscopy (SL) with or without laparoscopic ultrasound (LUS) on the surgical management of of pancreatico-biliary cancers.
Searching
Literature was searched using PubMed and the related articles function in PubMed (31 June 2009). Search terms were reported. There were no language restrictions. Bibliographies of identified articles were screened for additional studies.
Study selection
Studies that assessed the effect of preoperative staging using SL with or without LUS (SL/LUS) on the surgical management of patients with potentially resectable pancreatic/peripancreatic cancers (PPC) and proximal-biliary cancers (PBC) were eligible for inclusion. Gall bladder cancers and hilar and intrahepatic cholangiocarcinomas were included.
Included studies were required to use surgical evaluation as the reference standard for staging, except when laparoscopy detected obvious metastatic lesions (usually biopsy proven) or locally advanced disease, or confirmed benign pathology or absence of disease, that prevented surgical exploration.
